Radiofrequency ablation as a treatment strategy for liver metastases from breast cancer Journal Article


Authors: Covey, A. M.; Sofocleous, C. T.
Article Title: Radiofrequency ablation as a treatment strategy for liver metastases from breast cancer
Abstract: The American Cancer Society estimates that in 2007, 178,000 women in the United States will be diagnosed, and that 40,000 women will die from breast cancer. Metastatic breast cancer is a systemic disease, uncommonly involving an isolated organ. Liver metastases from breast cancer occur in -50% of the patients who develop breast cancer metastases and are associated with a poor outcome. Hepatic metastasectomy as an adjuvant treatment even in patients with stable extrahepatic disease has been shown to impart a significant survival advantage over chemotherapy alone. In the treatment of hepatocellular carcinoma (HCC) and colorectal liver metastases (CRLM), radiofrequency ablation (RFA) has been shown to be a safe, minimally invasive treatment option with low morbidity and short hospital stay that is more readily repeatable than resection. The data supporting RFA of breast cancer liver metastases (BCLM) is currently limited to small, retrospective series that, like hepatic resection, have demonstrated adjuvant RFA improves survival compared with chemotherapy alone. This review will examine the rationale, indications, supportive data, and complications of RFA in the treatment of BCLM. © 2008 by Thieme Medical Publishers.
Keywords: breast cancer; radiofrequency ablation; liver metastases; ablation
Journal Title: Seminars in Interventional Radiology
Volume: 25
Issue: 4
ISSN: 0739-9529
Publisher: Thieme Publishing  
Date Published: 2008-12-01
Start Page: 406
End Page: 412
Language: English
DOI: 10.1055/s-0028-1102996
PROVIDER: scopus
PMCID: PMC3036531
PUBMED: 21326582
DOI/URL:
Notes: --- - "Export Date: 17 November 2011" - "CODEN: SIRAE" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Anne Covey
    165 Covey
Related MSK Work